Gonococcal Isolate Surveillance Project
OMB 0920-0307
Robert Kirkcaldy, Project Officer
Attachment 8
Data Dictionary
GISP Data Elements
Demographic/Clinical Data (Form 1 or CDC 73.60A)
| Variable Name | Type/Length | Description | Values | |
| CLINIC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 YRMO 
 TOTYRMO 
 
 EPFEM 
 
 EPMALE 
 
 TOTEP 
 
 ID 
 CLINID 
 SEX 
 ETHNIC 
 AMIND 
 
 ASIAN 
 BLACK 
 NAHAW 
 
 WHITE 
 ORACE 
 DATEVIS | [Char, 3] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 [Char, 6] 
 [Char, 6] 
 
 [Num, 3] 
 
 [Num, 3] 
 
 [Num, 3] 
 
 [Char, 2] 
 [Char, 1] 
 [Char, 1] 
 [Char, 1] 
 [Char, 1] 
 
 [Char, 1] 
 [Char, 1] 
 [Char, 1] 
 
 [Char, 1] 
 [Char, 1] 
 [Date, 10] | Sentinel site code 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Year/Month of patient’s visit 
 Year/Month of clinic totals for gonorrhea 
 total monthly female gonorrhea episodes 
 total monthly male gonorrhea episodes 
 total monthly gonorrhea episodes 
 patient or isolate number 
 clinic identifier number 
 gender 
 Hispanic origin 
 American Indian/ Alaskan Native 
 Asian 
 Black 
 Native Hawaiian/ Pacific Islander 
 White 
 Other race 
 date of clinic visit | ALB=Albuquerque, ATL=Atlanta, BAL=Baltimore, BHM=Birmingham, CHI=Chicago, CIN=Cincinnati, CLE=Cleveland, DAL=Dallas, DEN=Denver, DTR=Detroit, GRB=Greensboro, HON=Honolulu, KCY=Kansas City, LAX=Los Angeles, LVG=Las Vegas, MIA=Miami, MIN=Minneapolis, NOR=New Orleans, NYC=New York City, OKC=Oklahoma City, ORA=Orange County, PHI=Philadelphia, PHX=Phoenix, POR=Portland, RIC=Richmond, SDG=San Diego, SEA=Seattle, SFO=San Francisco, TRP=Tripler Army Medical Center 
 
 YYYYMM 
 YYYYMM 
 
 
 
 
 
 
 
 
 
 
 01, 02, 03, ... 30 or higher 
 
 
 1=male, 2=female, 9=unknown 
 1=Hispanic, 2=non-Hispanic, 9=Unknown 
 1= yes, 2= no 
 
 1= yes, 2= no 
 1= yes, 2= no 
 1= yes, 2= no 
 
 1= yes, 2= no 
 1= yes, 2= no 
 MM/DD/YYYY | |
| DOB AGE SEXOR 
 
 SYMP 
 
 REASON 
 
 HISTORY 
 EPSDS 
 
 
 ZIP 
 HIVSTAT 
 
 TRAVEL 
 
 SEXWK 
 
 
 ANTIBIOT 
 
 IDU 
 
 NONIDU 
 
 
 
 
 
 
 
 
 | [Date, 10] [Num, 2] [Char, 1] 
 
 [Char, 1] 
 
 [Char, 1] 
 
 [Char, 1] 
 [Num, 2] 
 
 
 [Char, 5] 
 [Char, 1] 
 
 [Char, 1] 
 
 [Char, 1] 
 
 
 [Char, 1] 
 
 [Char, 1] 
 
 [Char, 1] 
 
 
 
 
 
 
 
 
 
 
 | date of birth age in years sexual orientation 
 
 symptoms of gonorrhea 
 
 reason for clinic visit 
 
 previous history of gonorrhea 
 number of previous episodes within the past 12 months 
 
 zip code (residential) 
 most recent known HIV status at clinic visit for gonorrhea 
 travel to Hawaii or outside U.S. in the previous 60 days 
 history of giving or receiving drugs/money for sex in the previous 60 days 
 any antibiotic use during the previous 60 days 
 history of injection drug use in previous 60 days 
 history of noninjection recreational drug use (excluding alcohol) in the previous 60 days 
 
 
 
 
 
 
 | MM/DD/YYYY 
					 1= heterosexual, 2= homosexual, 3=bisexual, 9= unknown 
 1= discharge and/or dysuria, 2= no discharge or dysuria, 9= symptoms unknown 
 1=volunteer, 2=contact of gonorrhea patient, 3=test of cure, 8=other, 9=unknown 
 1=yes, 2=no, 9=unknown 
 0=no documented previous episodes in the past 12 months 99=unknown (patient record not available) 
 00000=homeless, 99999=unknown 
 1=positive, 2=negative, 3=indeterminate, 9=unknown 
 1=yes, 2=no, 9=unknown 
 
 1=yes, 2=no, 9=unknown 
 
 
 1=yes, 2=no, 9=unknown 
 
 1=yes, 2=no, 9=unknown 
 
 1=yes, 2=no, 9=unknown 
 | |
| 
					 TRMT1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 OTHTRMT1 
 
 TRMT2 | 
					 [Char, 2] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 [Char, 15] 
 
 [Char, 2] | 
					 primary treatment for gonorrhea 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 alternative primary therapy for gonorrhea 
 treatment for presumptive chlamydial coinfection | 
					 00=none, 03=spectinomycin (Trobicin) 2 g, 04=ceftriaxone (Rocephin) 250 mg, 05=ceftriaxone (Rocephin) 125 mg, 06=ciprofloxacin (Cipro) 500 mg, 07=cefoxitin (Mefoxin) 2 g, 12=cefixime (Suprax) 400 mg, 14=cefpodoxime proxetil (Vantin) 200 mg, 15=ofloxacin (Floxin) 400 mg, 17=ceftizoxime (Cefizox) 500 mg, 18=cefotaxime (Claforan) 500 mg, 21=azithromycin (Zithromax) 2 g, 22=levofloxacin (Levaquin) 250 mg, 23=cefpodoxime proxetil (Vantin) 400 mg, 24=ceftibuten (Cedax) 400 mg, 25=cefdinir (Omnicef) 300 mg, 26=cefdinir (Omnicef) 600 mg, 88=other (please indicate in othtrmt1), 99=unknown 
 If code 88 was entered for Treatment 1, write in the name of the alternative 
 00=none, 01=ampicillin/amoxicillin, 09=doxycycline (Vibramycin)/tetracycline, 10=erythromycin, 11=azithromycin (Zithromax) 1 gm, 15=ofloxacin (Floxin), 88=other, 99=unknown | |
GISP Data Elements
Antimicrobial Susceptibility Testing (Form 2 or CDC 73.60B)
| Variable Name | Type/Length | Description | Values | 
| 
				 CLINIC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 YRMO 
 ID 
 B_LAC 
 PEN 
 
 TETRACY 
 
 SPCTINO 
 CFX 
 
 CRO 
 
 CIPRO 
 
 CPD 
 
 AZI 
 
 DATETEST 
 CONTROL | 
				 [Char, 3] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 [Char, 6] 
 [Char, 2] 
 [Char, 1] 
 [Num, 6] 
 
 [Num, 6] 
 
 [Char, 1] 
 [Num, 6] 
 
 [Num, 6] 
 
 [Num, 6] 
 
 [Num, 6] 
 
 [Num, 6] 
 
 [Date, 10] 
 [Char, 1] | 
				 Sentinel site code 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Year/ Month of patient's visit 
 patient or isolate number 
 beta-lactamase test 
 penicillin MIC 
 
 tetracycline MIC 
 
 spectinomycin sensitivity 
 cefixime MIC 
 
 ceftriaxone MIC 
 
 ciprofloxacin MIC 
 
 cefpodoxime MIC 
 
 azithromycin MIC 
 
 date isolate tested 
 Control ID | 
				 ALB=Albuquerque, ATL=Atlanta, BAL=Baltimore, BHM=Birmingham, CHI=Chicago, CIN=Cincinnati, CLE=Cleveland, DAL=Dallas, DEN=Denver, DTR=Detroit, GRB=Greensboro, HON=Honolulu, KCY=Kansas City, LAX=Los Angeles, LVG=Las Vegas, MIA=Miami, MIN=Minneapolis, NOR=New Orleans, NYC=New York City, OKC=Oklahoma City, ORA=Orange County, PHI=Philadelphia, PHX=Phoenix, POR=Portland, RIC=Richmond, SDG=San Diego, SEA=Seattle, SFO=San Francisco, TRP=Tripler Army Medical Center 
 01, 02, 03, ... 30 or higher 
 1=positive, 2=negative 
 0.0008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0; 32.0; 64.0 
 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0; 32.0; 64.0 
 1=sensitive; 2=resistant 
 0.002; 0004; 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0 
 0.001; 0.002; 0.004; 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0 
 0.001; 0.002; 0.004; 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0; 32.0 
 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0 
 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0 
 MM/DD/YYYY A, B, C, D | 
GISP Data Elements
Control Strain Susceptibility Testing (Form 3 or CDC 73.60C)
| Variable Name | Type/Length | Description | Values | 
| LAB 
 
 
 
 
 CONTROL 
 STRAIN 
 
 
 
 
 
 
 B_LAC 
 PEN 
 
 TETRACY 
 
 SPCTINO 
 CFX 
 
 CRO 
 
 CIPRO 
 
 CPD 
 
 AZI 
 
 DATETEST | [Char, 3] 
 
 
 
 
 [Char, 1] 
 [Char, 9] 
 
 
 
 
 
 
 [Char, 1] 
 [Num, 6] 
 
 [Num, 6] 
 
 [Char, 1] 
 [Num, 6] 
 
 [Num, 6] 
 
 [Num, 6] 
 
 [Num, 6] 
 
 [Num, 6] 
 
 [Date, 10] 
 | Regional laboratory 
 
 
 
 
 Control ID 
 strain number 
 
 
 
 
 
 
 beta-lactamase test 
 penicillin MIC 
 
 tetracycline MIC 
 
 spectinomycin sensitivity 
 cefixime MIC 
 
 ceftriaxone MIC 
 
 ciprofloxacin MIC 
 
 cefpodoxime MIC 
 
 azithromycin MIC 
 
 date of isolate testing 
 | EMO=Atlanta regional lab UAB=Birmingham regional lab CLV=Cleveland regional lab TEX=Texas regional lab UWA=Seattle regional lab 
 A, B, C, D 
 F-18 F-28 SPL-4 P681E CDC 10328 CDC 10329 SPJ-15 
 1=positive, 2=negative 
 0.0008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0; 32.0; 64.0 
 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0; 32.0; 64.0 
 1=sensitive; 2=resistant 
 0.002; 0004; 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0 
 0.001; 0.002; 0.004; 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0 
 0.001; 0.002; 0.004; 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0; 32.0 
 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0 
 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0 
 MM/DD/YYYY | 
		-
	
| File Type | application/msword | 
| File Title | GISP Data Elements | 
| Author | Alesia Harvey | 
| Last Modified By | ixl3 | 
| File Modified | 2010-06-24 | 
| File Created | 2010-06-11 |